这是一篇来自已证抗体库的有关人类 CD25的综述,是根据264篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD25 抗体。
CD25 同义词: CD25; IDDM10; IL2R; IMD41; TCGFR; p55

BioLegend
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s6-2
BioLegend CD25抗体(BioLegend, MA251)被用于被用于流式细胞仪在人类样本上 (图 s6-2). elife (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 6c
BioLegend CD25抗体(Biolegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 6c). Cell Death Dis (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 3b
BioLegend CD25抗体(Biolegend, 356102)被用于被用于流式细胞仪在人类样本上 (图 3b). elife (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 小鼠; 1:100
BioLegend CD25抗体(Biolegend, M-A25)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. elife (2020) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 小鼠; 图 2a
BioLegend CD25抗体(BioLegend, 302636)被用于被用于流式细胞仪在小鼠样本上 (图 2a). Cell (2020) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s1d
BioLegend CD25抗体(Biolegend, 302632)被用于被用于流式细胞仪在人类样本上 (图 s1d). Cell (2020) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s6a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 s6a). J Clin Invest (2020) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1c
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1c). JCI Insight (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s20
BioLegend CD25抗体(Biolegend, 356113)被用于被用于流式细胞仪在人类样本上 (图 s20). Science (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 1:200; 图 7c
BioLegend CD25抗体(BioLegend, 302613)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7c). elife (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 1:100; 图 7a
BioLegend CD25抗体(Biolegend, 302610)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 7a). elife (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 7a, 7b, 7c
BioLegend CD25抗体(Biolegend, clone BC96)被用于被用于流式细胞仪在人类样本上 (图 7a, 7b, 7c). Sci Rep (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3d
BioLegend CD25抗体(Biolegend, 356102)被用于被用于流式细胞仪在人类样本上 (图 s3d). Cell (2019) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3d
BioLegend CD25抗体(Biolegend, 356102)被用于被用于流式细胞仪在人类样本上 (图 s3d). Cell (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 3s2b
BioLegend CD25抗体(Biolegend, 302609)被用于被用于流式细胞仪在人类样本上 (图 3s2b). elife (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 小鼠; 图 6d
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在小鼠样本上 (图 6d). J Clin Invest (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 s1). J Exp Med (2019) ncbi
小鼠 单克隆(BC96)
  • 其他; 人类; 图 4b
BioLegend CD25抗体(BioLegend, 302643)被用于被用于其他在人类样本上 (图 4b). Cell (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD25抗体(BioLegend, 302610)被用于被用于流式细胞仪在人类样本上 (图 4a). Diagn Pathol (2019) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD25抗体(Biolegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 3a). Front Immunol (2019) ncbi
小鼠 单克隆(M-A251)
  • mass cytometry; 人类; 图 2b
BioLegend CD25抗体(Biolegend, 356102)被用于被用于mass cytometry在人类样本上 (图 2b). Cell (2019) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s2c
BioLegend CD25抗体(Biolegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s2c). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(BC96)
  • 免疫细胞化学; 人类; 图 6c
BioLegend CD25抗体(Biolegend, 302615)被用于被用于免疫细胞化学在人类样本上 (图 6c). Sci Rep (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s10d
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 s10d). Nature (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 7a
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 7a). Front Pharmacol (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 3g
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 3g). Cell Stem Cell (2019) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD25抗体(Biolegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 3a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 猕猴; 图 7a
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在猕猴样本上 (图 7a). J Virol (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 猕猴; 图 2f
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在猕猴样本上 (图 2f). J Virol (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1e
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1e). PLoS Pathog (2018) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD25抗体(BioLegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1a). Leukemia (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1a). Bone Marrow Transplant (2018) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1b). J Exp Med (2018) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1). Am J Trop Med Hyg (2018) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1
BioLegend CD25抗体(BioLegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1). Am J Trop Med Hyg (2018) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 4a). Int J Infect Dis (2018) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 7a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 7a). Nat Immunol (2018) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 3d
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 3d). Antimicrob Agents Chemother (2018) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 3g
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 3g). Int Immunopharmacol (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD25抗体(BioLegend, 302610)被用于被用于流式细胞仪在人类样本上 (图 2a). J Clin Invest (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 3c
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 3c). Oncotarget (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD25抗体(BioLegend, 356130)被用于被用于流式细胞仪在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
大鼠 单克隆(7D4/CD25)
  • 流式细胞仪; 小鼠; 图 7e
BioLegend CD25抗体(BioLegend, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 7e). J Exp Med (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1
BioLegend CD25抗体(Biolegend, 302612)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 6f
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 6f). J Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 7a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 7a). J Immunol (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 表 1
BioLegend CD25抗体(Biolegend, M-A251)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 猕猴; 图 2
BioLegend CD25抗体(BioLegend, 302630)被用于被用于流式细胞仪在猕猴样本上 (图 2). Science (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s7
BioLegend CD25抗体(Biolegend, 302630)被用于被用于流式细胞仪在人类样本上 (图 s7). Cell (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s2
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 s2). PLoS Pathog (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 1:100; 图 3f
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 3f). Nat Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 4a). J Exp Med (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1b). Eur J Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 小鼠
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在小鼠样本上. Science (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; African green monkey; 图 s2
BioLegend CD25抗体(BioLegend, M-A251)被用于被用于流式细胞仪在African green monkey样本上 (图 s2). J Med Primatol (2016) ncbi
大鼠 单克隆(7D4/CD25)
  • 流式细胞仪; 小鼠; 图 2a
BioLegend CD25抗体(BioLegend, 7D4)被用于被用于流式细胞仪在小鼠样本上 (图 2a). Cell Biosci (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1b). Nat Immunol (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 5b
BioLegend CD25抗体(BioLegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 5b). Am J Transplant (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 6b
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 6b). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 8a
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 8a). PLoS Pathog (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD25抗体(BioLegend, 302609)被用于被用于流式细胞仪在人类样本上 (图 s1). Sci Rep (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 3b
BioLegend CD25抗体(BioLegend, M-A251)被用于被用于流式细胞仪在人类样本上 (图 3b). Eur J Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1
BioLegend CD25抗体(BioLegend, 302606)被用于被用于流式细胞仪在人类样本上 (图 1). elife (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 5a
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 5a). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol Res (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 1). J Autoimmun (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 4
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上 (图 4). Nat Immunol (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
BioLegend CD25抗体(BioLegend, clone BC96)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(BC96)
BioLegend CD25抗体(Biolegend, 302606)被用于. PLoS ONE (2014) ncbi
小鼠 单克隆(M-A251)
BioLegend CD25抗体(Biolegend, M-A251)被用于. PLoS ONE (2014) ncbi
小鼠 单克隆(BC96)
BioLegend CD25抗体(Biolegend, 302606)被用于. J Biol Chem (2014) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
BioLegend CD25抗体(Biolegend, BC96)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2014) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 黑猩猩
BioLegend CD25抗体(BioLegend, BC96)被用于被用于流式细胞仪在黑猩猩样本上. J Med Primatol (2014) ncbi
赛默飞世尔
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s1c
赛默飞世尔 CD25抗体(eBioscience, 12-0259-42)被用于被用于流式细胞仪在人类样本上 (图 s1c). Cell (2019) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 1:100; 图 1b
赛默飞世尔 CD25抗体(Invitrogen, MHCD2501)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1b). Nat Commun (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2019) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔 CD25抗体(eBiosciences, BC96)被用于被用于流式细胞仪在人类样本上 (图 5a). Front Immunol (2018) ncbi
小鼠 单克隆(CD25-4E3)
  • 免疫组化-冰冻切片; 人类; 图 1a
赛默飞世尔 CD25抗体(eBioscience, CD25-4E3)被用于被用于免疫组化-冰冻切片在人类样本上 (图 1a). J Exp Med (2018) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD25抗体(ebioscience, BC96)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s2k
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上 (图 s2k). Nature (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD25抗体(eBioscience, 12-0259-42)被用于被用于流式细胞仪在人类样本上 (表 1). Cell (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1f
赛默飞世尔 CD25抗体(ebioscience, 17-0259)被用于被用于流式细胞仪在人类样本上 (图 1f). J Immunol (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 s1b
赛默飞世尔 CD25抗体(eBioscience, 48-0259)被用于被用于流式细胞仪在人类样本上 (图 s1b). Cell (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBiosciences, 17-0259-42)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD25抗体(eBiosciences, BC96)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 小鼠; 图 1
赛默飞世尔 CD25抗体(eBioscience, 25025942)被用于被用于流式细胞仪在小鼠样本上 (图 1). J Immunother Cancer (2016) ncbi
小鼠 单克隆(RPA-T4, BC96)
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD25抗体(eBioscience, RPA-T4)被用于被用于流式细胞仪在人类样本上 (图 s1). Cell Rep (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD25抗体(eBioscience, 25-0259-42)被用于被用于流式细胞仪在人类样本上 (图 4). J Clin Invest (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 4d
赛默飞世尔 CD25抗体(eBioscience, 17-0259-42)被用于被用于流式细胞仪在人类样本上 (图 4d). J Immunol (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(CD25-4E3)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD25抗体(eBioscience, 4E3)被用于被用于流式细胞仪在人类样本上 (图 4). Haematologica (2016) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(ebioscience, 17-0259-42)被用于被用于流式细胞仪在人类样本上. Am J Reprod Immunol (2015) ncbi
小鼠 单克隆(CD25-4E3)
  • 流式细胞仪; 食蟹猴; 图 s2
赛默飞世尔 CD25抗体(eBioscience, 4E3)被用于被用于流式细胞仪在食蟹猴样本上 (图 s2). J Autoimmun (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2014) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上 (图 1). Eur J Immunol (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上. Cytotherapy (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上. Leukemia (2015) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上. Cancer Res (2014) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
  • 免疫细胞化学; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上 和 被用于免疫细胞化学在人类样本上. Mol Oncol (2014) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上. J Immunol (2013) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD25抗体(Caltag, clone 3G10)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Exp Immunol (2012) ncbi
小鼠 单克隆(RPA-T4, BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, RPA-T4)被用于被用于流式细胞仪在人类样本上. Nat Immunol (2011) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD25抗体(Invitrogen, MHCD2504)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Invest (2012) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类; 图 S5
赛默飞世尔 CD25抗体(eBioscience, 25-0259-42)被用于被用于流式细胞仪在人类样本上 (图 S5). Proc Natl Acad Sci U S A (2012) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1, 2
赛默飞世尔 CD25抗体(Caltag, CD25.3G10)被用于被用于流式细胞仪在人类样本上 (图 1, 2). Cancer Res (2011) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 大鼠; 25 ug/ml; 表 2
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在大鼠样本上浓度为25 ug/ml (表 2). Arthritis Res Ther (2011) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 4). Br J Dermatol (2010) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(eBioscience, BC96)被用于被用于流式细胞仪在人类样本上. J Exp Med (2009) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 猕猴; 图 3
赛默飞世尔 CD25抗体(Caltag, 3G10)被用于被用于流式细胞仪在猕猴样本上 (图 3). Am J Transplant (2008) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 3b). Lupus (2008) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD25抗体(Invitrogen, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 5). Cancer Immunol Immunother (2009) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Exp Immunol (2008) ncbi
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(e-Bioscience, BC96)被用于被用于流式细胞仪在人类样本上. Immunology (2008) ncbi
小鼠 单克隆(B-B10)
  • 免疫印迹; 仓鼠; 图 7
赛默飞世尔 CD25抗体(BioSource/Invitrogen Corp, B-B10)被用于被用于免疫印迹在仓鼠样本上 (图 7). J Biol Chem (2007) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 6A
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 6A). Int Immunol (2007) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 2A
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 2A). FASEB J (2006) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD25抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol Methods (2006) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1B
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 1B). Rheumatology (Oxford) (2006) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 5). Biol Blood Marrow Transplant (2006) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD25抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上 (图 5). Biochem Biophys Res Commun (2005) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上. Cancer Immunol Immunother (2006) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上. Methods Mol Biol (2005) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2005) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上. Scand J Gastroenterol (2004) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上. J Hepatol (2004) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD25抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上 (图 4). Eur J Immunol (2003) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD25抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上 (图 4). J Rheumatol (2003) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上. Cancer Immunol Immunother (2003) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD25抗体(Caltag, 3G10)被用于被用于流式细胞仪在人类样本上 (图 1a). Blood (2001) ncbi
小鼠 单克隆(B-B10)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD25抗体(BioSource International, B-B10)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2001) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2001) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(Caltag, CD25-3G10)被用于被用于流式细胞仪在人类样本上. Infect Immun (2000) ncbi
小鼠 单克隆(B-B10)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD25抗体(Biosource, B-B10)被用于被用于流式细胞仪在人类样本上 (图 2). J Interferon Cytokine Res (1999) ncbi
小鼠 单克隆(CD25-3G10)
  • 流式细胞仪; 人类
赛默飞世尔 CD25抗体(BioSource, CD25-3g10)被用于被用于流式细胞仪在人类样本上. J Immunol (1998) ncbi
小鼠 单克隆(CD25-3G10)
  • 抑制或激活实验; 人类; 1:256
赛默飞世尔 CD25抗体(noco, noca)被用于被用于抑制或激活实验在人类样本上浓度为1:256. J Immunol (1981) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(AV142)
  • 流式细胞仪; 鸡; 图 1
伯乐(Bio-Rad)公司 CD25抗体(BIO-RAD AbD Serotec, AV142)被用于被用于流式细胞仪在鸡样本上 (图 1). Parasite Immunol (2016) ncbi
小鼠 单克隆(AV142)
  • 流式细胞仪; 鸡; 图 3
伯乐(Bio-Rad)公司 CD25抗体(AbD Serotec, AV142)被用于被用于流式细胞仪在鸡样本上 (图 3). Dev Comp Immunol (2015) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(MEM-181)
  • 免疫细胞化学; 小鼠; 1:1000
艾博抗(上海)贸易有限公司 CD25抗体(Abcam, ab8235)被用于被用于免疫细胞化学在小鼠样本上浓度为1:1000. J Comp Neurol (2014) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; 人类; 图 s1
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman Coulter, B1.49.9)被用于被用于流式细胞仪在人类样本上 (图 s1). EBioMedicine (2020) ncbi
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; 人类; 图 s8a
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman Coulter, B1.49.9)被用于被用于流式细胞仪在人类样本上 (图 s8a). Nat Commun (2020) ncbi
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; 人类; 图 1
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman Coulter, IM2646U)被用于被用于流式细胞仪在人类样本上 (图 1). Exp Ther Med (2017) ncbi
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; 人类; 图 1a
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman Coulter-Immunotech, B1.49.9)被用于被用于流式细胞仪在人类样本上 (图 1a). New Microbiol (2016) ncbi
小鼠 单克隆(B1.49.9)
  • 免疫细胞化学; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman Coulter, B1.49.9)被用于被用于免疫细胞化学在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman Coulter, A52882)被用于被用于流式细胞仪在人类样本上. Ann Neurol (2014) ncbi
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman Coulter, B1.49.9)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2014) ncbi
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman, cB1.49.9)被用于被用于流式细胞仪在人类样本上. Cancer Res (2014) ncbi
小鼠 单克隆(B1.49.9)
  • 流式细胞仪; South American squirrel monkey
贝克曼库尔特实验系统(苏州)有限公司 CD25抗体(Beckman, B1.49.9)被用于被用于流式细胞仪在South American squirrel monkey样本上. J Immunol Methods (2005) ncbi
Tonbo Biosciences
小鼠 单克隆(BC96)
  • 流式细胞仪; 人类
Tonbo Biosciences CD25抗体(Tonbo Biosciences, BC96)被用于被用于流式细胞仪在人类样本上. J Clin Invest (2016) ncbi
碧迪BD
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3d
碧迪BD CD25抗体(Becton Dickinson, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s3d). EBioMedicine (2020) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 s3d
碧迪BD CD25抗体(Becton Dickinson, 2A3)被用于被用于流式细胞仪在人类样本上 (图 s3d). EBioMedicine (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3b
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s3b). Aging (Albany NY) (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD25抗体(BD Biosciences, M-251)被用于被用于流式细胞仪在人类样本上 (图 1d). Arch Immunol Ther Exp (Warsz) (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 7k
碧迪BD CD25抗体(BD, MA-251)被用于被用于流式细胞仪在人类样本上 (图 7k). J Exp Med (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1c). J Immunother Cancer (2020) ncbi
小鼠 单克隆(2A3)
  • mass cytometry; 人类; 0.5 mg/ml; 图 s11a
碧迪BD CD25抗体(BD, 2A3)被用于被用于mass cytometry在人类样本上浓度为0.5 mg/ml (图 s11a). Nature (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 14a
碧迪BD CD25抗体(BD Biosciences, 560987)被用于被用于流式细胞仪在人类样本上 (图 14a). Hum Vaccin Immunother (2020) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2019) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 3f, 3g
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (图 3f, 3g). Brain Pathol (2020) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 s7a
碧迪BD CD25抗体(BD Biosciences, 340939)被用于被用于流式细胞仪在人类样本上 (图 s7a). Cell (2019) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 7a
碧迪BD CD25抗体(BD Biosciences, 341009)被用于被用于流式细胞仪在人类样本上 (图 7a). elife (2019) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (图 s3). Eur J Immunol (2019) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD25抗体(BD Pharmingen, 2A3)被用于被用于流式细胞仪在人类样本上 (图 1). Am J Transplant (2019) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s5a
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s5a). Proc Natl Acad Sci U S A (2018) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 1:20; 图 2a
碧迪BD CD25抗体(BD Bioscience, 340907)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 2a). Nat Med (2019) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 5b
碧迪BD CD25抗体(BD Biosciences, 564033)被用于被用于流式细胞仪在人类样本上 (图 5b). Nat Immunol (2018) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD25抗体(BD Biosciences, 560503)被用于被用于流式细胞仪在人类样本上 (表 1). J Clin Invest (2018) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s2l
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s2l). JCI Insight (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD25抗体(BD Biosciences, MA-251)被用于被用于流式细胞仪在人类样本上 (图 4a). PLoS ONE (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 表 s1
碧迪BD CD25抗体(BD Pharmingen, 555432)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (图 5a). Sci Rep (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s1b). PLoS ONE (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1c). Sci Rep (2017) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 s3c
碧迪BD CD25抗体(BD, 2A3)被用于被用于流式细胞仪在人类样本上 (图 s3c). J Clin Invest (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s1d
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s1d). J Immunol (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD25抗体(BD Pharmingen, 560225)被用于被用于流式细胞仪在人类样本上 (图 3a). Cell Res (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 4d
碧迪BD CD25抗体(BD Biosciences, 555432)被用于被用于流式细胞仪在人类样本上 (图 4d). Oncoimmunology (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 5a). Blood (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3a
碧迪BD CD25抗体(BD Bioscience, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s3a). Sci Rep (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1a). JCI Insight (2017) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 2e
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (图 2e). Am J Transplant (2017) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s1c
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s1c). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (图 1a). Int J Cancer (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD, MA- 251)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 3a). Cancer Res (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD25抗体(BD, 2A3)被用于被用于流式细胞仪在人类样本上 (图 4a). J Allergy Clin Immunol (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2017) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 8
碧迪BD CD25抗体(BD Biosciences, 555432)被用于被用于流式细胞仪在人类样本上 (图 8). Nat Immunol (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Bioscience, 2A3)被用于被用于流式细胞仪在人类样本上. Science (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 s2f
碧迪BD CD25抗体(BD, 2A3)被用于被用于流式细胞仪在人类样本上 (图 s2f). J Clin Invest (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上. Sci Rep (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Pharmingen, 555433)被用于被用于流式细胞仪在人类样本上. Turk J Haematol (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (图 s1). JCI Insight (2016) ncbi
小鼠 单克隆(M-A251)
  • 免疫印迹; 小鼠; 1:1000; 图 s10a
碧迪BD CD25抗体(BD Biosciences, 555430)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s10a). Nat Commun (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 1:5; 表 2
碧迪BD CD25抗体(BD PharMingen, 555434)被用于被用于流式细胞仪在人类样本上浓度为1:5 (表 2). Oncoimmunology (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1d). PLoS ONE (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD25抗体(BD, 2A3)被用于被用于流式细胞仪在人类样本上 (图 s2). Am J Transplant (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD25抗体(BD, 557138)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, 557741)被用于被用于流式细胞仪在人类样本上. Haematologica (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD25抗体(BD, 555434)被用于被用于流式细胞仪在人类样本上 (图 2). Nat Biotechnol (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 7
碧迪BD CD25抗体(BD Biosciences, 555434)被用于被用于流式细胞仪在人类样本上 (图 7). Immunity (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (图 st1). J Autoimmun (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunol (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (图 5a). PLoS ONE (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 7.45.3
碧迪BD CD25抗体(BD Biosciences, 341010)被用于被用于流式细胞仪在人类样本上 (图 7.45.3). Curr Protoc Cytom (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD25抗体(BD biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 5a). Immunol Res (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 8c
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 8c). J Biol Chem (2016) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上. J Immunol (2016) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s6
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s6). PLoS ONE (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 1:25; 表 1
碧迪BD CD25抗体(BD Pharmingen, 555434)被用于被用于流式细胞仪在人类样本上浓度为1:25 (表 1). PLoS ONE (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Transl Med (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD25抗体(BD Biosciences, 560355)被用于被用于流式细胞仪在人类样本上 (图 1). Retrovirology (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD25抗体(BD Biosciences, MA251)被用于被用于流式细胞仪在人类样本上 (图 2). J Clin Invest (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. Respir Res (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD25抗体(BD PharMingen, 557753)被用于被用于流式细胞仪在人类样本上 (图 2b). PLoS ONE (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 1:100; 图 6
碧迪BD CD25抗体(BD Bioscience, 555431)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 6). Stem Cells Int (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Pharmingen, 555433)被用于被用于流式细胞仪在人类样本上. Cent Eur J Immunol (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1c,1f,5b,5d
碧迪BD CD25抗体(BD, 561405)被用于被用于流式细胞仪在人类样本上 (图 1c,1f,5b,5d). PLoS Pathog (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, clone M-A251)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD25抗体(BD Bioscience, M-A251)被用于被用于流式细胞仪在人类样本上 (图 5). Nat Immunol (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. Sci Transl Med (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (图 2). Retrovirology (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD25抗体(BD Biosciences, MA-251)被用于被用于流式细胞仪在人类样本上 (图 s3). J Infect Dis (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 小鼠; 图 3
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在小鼠样本上 (图 3). Stem Cell Res (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 1 ul/test
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上浓度为1 ul/test. J Immunol Methods (2015) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上 (图 1). J Autoimmun (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Bioscience, M-A251)被用于被用于流式细胞仪在人类样本上. Clin Transplant (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Bioscience, M-A251)被用于被用于流式细胞仪在人类样本上. Cell Res (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s3). Diabetes (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Pharmingen, 555431)被用于被用于流式细胞仪在人类样本上. Alcohol (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 6
碧迪BD CD25抗体(BD Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (图 6). Stem Cell Res Ther (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 1:20
碧迪BD CD25抗体(BD Biosciences, MA-251)被用于被用于流式细胞仪在人类样本上浓度为1:20. Autoimmun Rev (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 猕猴
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在猕猴样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(Becton Dickinson Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上. J Autoimmun (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(Becton Dickinson Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. J Autoimmun (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上. Nat Commun (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上. Nat Immunol (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上 (图 5). Clin Cancer Res (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD25抗体(BD Biosciences, MA-251)被用于被用于流式细胞仪在人类样本上 (图 2). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(M-A251)
  • 免疫细胞化学; 小鼠
碧迪BD CD25抗体(PharMingen, M-A251)被用于被用于免疫细胞化学在小鼠样本上. Hum Pathol (2014) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Pharmigen, 2A3)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Pharmigen, M-A251)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. Immunobiology (2015) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上. Immunobiology (2015) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD25抗体(BD Bioscience, M-A251)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 4b
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上 (图 4b). Biol Blood Marrow Transplant (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 3b
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上 (图 3b). Eur J Immunol (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD25抗体(Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上 (图 2). Immunology (2015) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(Becton Dickinson Pharmingen, 341009)被用于被用于流式细胞仪在人类样本上. J Immunol Methods (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Bioscience, M-A251)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(M-A251)
  • 免疫细胞化学; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于免疫细胞化学在人类样本上. Eur J Immunol (2014) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD25抗体(BD, M-A251)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD/Pharmingen, M-A251)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(M-A251)
  • 流式细胞仪; 人类
碧迪BD CD25抗体(BD Biosciences, M-A251)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2014) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; 小鼠; 图 1
碧迪BD CD25抗体(BD Biosciences, 2A3)被用于被用于流式细胞仪在小鼠样本上 (图 1). Blood (2007) ncbi
小鼠 单克隆(2A3)
  • 流式细胞仪; South American squirrel monkey
碧迪BD CD25抗体(BDIS, 2A3)被用于被用于流式细胞仪在South American squirrel monkey样本上. J Immunol Methods (2005) ncbi
徕卡显微系统(上海)贸易有限公司
单克隆(4C9)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 1
徕卡显微系统(上海)贸易有限公司 CD25抗体(Novocastra, 4C9)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 1). Rom J Morphol Embryol (2016) ncbi
单克隆(4C9)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 6
徕卡显微系统(上海)贸易有限公司 CD25抗体(Leica Microsystems, PA0306)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 6). Am J Surg Pathol (2015) ncbi
单克隆(4C9)
  • 免疫组化-石蜡切片; 人类; 1:50
徕卡显微系统(上海)贸易有限公司 CD25抗体(Leica, 4C9)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. Int J Lab Hematol (2015) ncbi
单克隆(4C9)
  • 免疫组化-石蜡切片; 人类; 1:50
徕卡显微系统(上海)贸易有限公司 CD25抗体(Novocastra, 4C9)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. Br J Dermatol (2015) ncbi
单克隆(4C9)
  • 免疫组化-石蜡切片; 人类
徕卡显微系统(上海)贸易有限公司 CD25抗体(Leica Novocastra, 4C9)被用于被用于免疫组化-石蜡切片在人类样本上. PLoS ONE (2014) ncbi
文章列表
  1. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed 出版商
  2. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed 出版商
  3. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed 出版商
  4. Fernandes R, Li C, Wang G, Yang X, Savvides C, Glassman C, et al. Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo. elife. 2020;9: pubmed 出版商
  5. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed 出版商
  6. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed 出版商
  7. Fischer M, Ruhnau J, Schulze J, Obst D, Floel A, Vogelgesang A. Spermine and spermidine modulate T-cell function in older adults with and without cognitive decline ex vivo. Aging (Albany NY). 2020;12:13716-13739 pubmed 出版商
  8. Janyst M, Kaleta B, Janyst K, Zagozdzon R, Kozlowska E, Lasek W. Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin. Arch Immunol Ther Exp (Warsz). 2020;68:20 pubmed 出版商
  9. Oh D, Kwek S, Raju S, Li T, McCarthy E, Chow E, et al. Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell. 2020;181:1612-1625.e13 pubmed 出版商
  10. Kuhny M, Forbes L, Çakan E, Vega Loza A, Kostiuk V, Dinesh R, et al. Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID. J Clin Invest. 2020;: pubmed 出版商
  11. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed 出版商
  12. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed 出版商
  13. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed 出版商
  14. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed 出版商
  15. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed 出版商
  16. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed 出版商
  17. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed 出版商
  18. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed 出版商
  19. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed 出版商
  20. Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed 出版商
  21. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed 出版商
  22. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed 出版商
  23. Pham J. One Year at Cell: Looking Back and Moving Forward with Purpose. Cell. 2019;178:1273-1274 pubmed 出版商
  24. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed 出版商
  25. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed 出版商
  26. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed 出版商
  27. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed 出版商
  28. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed 出版商
  29. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed 出版商
  30. Canete P, Sweet R, Gonzalez Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;: pubmed 出版商
  31. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed 出版商
  32. Han L, Hu J, Ma B, Wen D, Zhang T, Lu Z, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol. 2019;14:52 pubmed 出版商
  33. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed 出版商
  34. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed 出版商
  35. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed 出版商
  36. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed 出版商
  37. Pais H, Ruggero K, Zhang J, Al Assar O, Bery N, Bhuller R, et al. Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model. Sci Rep. 2019;9:5760 pubmed 出版商
  38. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed 出版商
  39. Talreja J, Talwar H, Bauerfeld C, Grossman L, Zhang K, Tranchida P, et al. HIF-1α regulates IL-1β and IL-17 in sarcoidosis. elife. 2019;8: pubmed 出版商
  40. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  41. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed 出版商
  42. Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, et al. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Front Pharmacol. 2019;10:39 pubmed 出版商
  43. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed 出版商
  44. Koppejan H, Jansen D, Hameetman M, Thomas R, Toes R, van Gaalen F. Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis. Arthritis Res Ther. 2019;21:3 pubmed 出版商
  45. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed 出版商
  46. Harper I, Gjorgjimajkoska O, Siu J, Parmar J, Mulder A, Claas F, et al. Prolongation of allograft survival by passenger donor regulatory T cells. Am J Transplant. 2019;19:1371-1379 pubmed 出版商
  47. Helmold Hait S, Vargas Inchaustegui D, Musich T, Mohanram V, Tuero I, Venzon D, et al. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques. J Virol. 2019;93: pubmed 出版商
  48. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed 出版商
  49. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed 出版商
  50. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed 出版商
  51. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed 出版商
  52. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed 出版商
  53. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed 出版商
  54. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed 出版商
  55. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed 出版商
  56. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed 出版商
  57. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed 出版商
  58. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed 出版商
  59. Zemmour D, Zilionis R, Kiner E, Klein A, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. 2018;19:291-301 pubmed 出版商
  60. Tobin L, Mavinkurve M, Carolan E, Kinlen D, O Brien E, Little M, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2: pubmed 出版商
  61. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed 出版商
  62. Meng W, Tang A, Ye X, Gui X, Li L, Fan X, et al. Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody. Antimicrob Agents Chemother. 2018;62: pubmed 出版商
  63. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  64. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed 出版商
  65. Liaskou E, Jeffery L, Chanouzas D, Soskic B, Seldin M, Harper L, et al. Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals. Sci Rep. 2017;7:7652 pubmed 出版商
  66. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  67. Meniailo M, Malashchenko V, Shmarov V, Gazatova N, Melashchenko O, Goncharov A, et al. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017;50:178-185 pubmed 出版商
  68. de Wolf A, van Aalst S, Ludwig I, Bodinham C, Lewis D, van der Zee R, et al. Regulatory T cell frequencies and phenotypes following anti-viral vaccination. PLoS ONE. 2017;12:e0179942 pubmed 出版商
  69. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed 出版商
  70. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed 出版商
  71. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed 出版商
  72. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed 出版商
  73. Ventura E, Weller M, Burghardt I. Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-? and Furin in Glioma-Initiating Cells. J Immunol. 2017;198:4569-4574 pubmed 出版商
  74. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed 出版商
  75. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed 出版商
  76. Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol. 2017;198:3803-3808 pubmed 出版商
  77. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed 出版商
  78. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed 出版商
  79. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed 出版商
  80. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed 出版商
  81. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed 出版商
  82. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed 出版商
  83. Aagaard K, Lahon A, Suter M, Arya R, Seferovic M, Vogt M, et al. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication. Sci Rep. 2017;7:41389 pubmed 出版商
  84. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed 出版商
  85. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed 出版商
  86. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  87. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed 出版商
  88. Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed 出版商
  89. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  90. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  91. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  92. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  93. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  94. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed 出版商
  95. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  96. Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, et al. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. New Microbiol. 2016;39:247-258 pubmed
  97. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  98. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed 出版商
  99. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  100. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed 出版商
  101. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed 出版商
  102. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed 出版商
  103. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed 出版商
  104. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed 出版商
  105. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed 出版商
  106. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed 出版商
  107. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed 出版商
  108. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed 出版商
  109. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed 出版商
  110. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed 出版商
  111. Goodier M, Rodríguez Galán A, Lusa C, Nielsen C, Darboe A, Moldoveanu A, et al. Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection. J Immunol. 2016;197:313-25 pubmed 出版商
  112. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  113. Akyol Erikci A, Karagoz B, Bilgi O. Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura. Turk J Haematol. 2016;33:153-5 pubmed 出版商
  114. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed 出版商
  115. Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunother Cancer. 2016;4:28 pubmed 出版商
  116. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun. 2016;7:11471 pubmed 出版商
  117. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed 出版商
  118. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed 出版商
  119. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  120. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  121. Wattrang E, Thebo P, Lunden A, Dalgaard T. Monitoring of local CD8β-expressing cell populations during Eimeria tenella infection of naïve and immune chickens. Parasite Immunol. 2016;38:453-67 pubmed 出版商
  122. Harper I, Ali J, Harper S, Wlodek E, Alsughayyir J, Negus M, et al. Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep. 2016;15:1214-27 pubmed 出版商
  123. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed 出版商
  124. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed 出版商
  125. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed 出版商
  126. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed 出版商
  127. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  128. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed 出版商
  129. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  130. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  131. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed 出版商
  132. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed 出版商
  133. Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V, Galgani M, et al. The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements. Immunity. 2016;44:406-21 pubmed 出版商
  134. Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G, et al. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016;68:98-104 pubmed 出版商
  135. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed 出版商
  136. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed 出版商
  137. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  138. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  139. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed 出版商
  140. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed 出版商
  141. Berges C, Chatterjee M, Topp M, Einsele H. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Immunol Res. 2016;64:687-98 pubmed 出版商
  142. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed 出版商
  143. Whisenant T, Peralta E, Aarreberg L, Gao N, Head S, Ordoukhanian P, et al. The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells. PLoS ONE. 2015;10:e0144409 pubmed 出版商
  144. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed 出版商
  145. Dimeloe S, Mehling M, Frick C, Loeliger J, Bantug G, Sauder U, et al. The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions. J Immunol. 2016;196:106-14 pubmed 出版商
  146. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed 出版商
  147. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed 出版商
  148. Laborel Préneron E, Bianchi P, Boralevi F, Lehours P, Fraysse F, Morice Picard F, et al. Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the Skin Microbiota of Atopic Children on CD4+ T Cell Activation. PLoS ONE. 2015;10:e0141067 pubmed 出版商
  149. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed 出版商
  150. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  151. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed 出版商
  152. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed 出版商
  153. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed 出版商
  154. Bézie S, Picarda E, Ossart J, Tesson L, Usal C, Renaudin K, et al. IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest. 2015;125:3952-64 pubmed 出版商
  155. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed 出版商
  156. Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, et al. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS ONE. 2015;10:e0137881 pubmed 出版商
  157. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed 出版商
  158. Moslem M, Eberle I, Weber I, Henschler R, Cantz T. Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction. Stem Cells Int. 2015;2015:843058 pubmed 出版商
  159. Biylgi O, Karagöz B, Türken O, Gültepe M, Özgün A, Tunçel T, et al. CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Cent Eur J Immunol. 2014;39:338-44 pubmed 出版商
  160. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed 出版商
  161. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  162. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed 出版商
  163. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed 出版商
  164. Hanley P, Melenhorst J, Nikiforow S, Scheinberg P, Blaney J, Demmler Harrison G, et al. CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med. 2015;7:285ra63 pubmed 出版商
  165. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed 出版商
  166. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed 出版商
  167. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  168. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed 出版商
  169. Rao T, Marks Bluth J, Sullivan J, Gupta M, Chandrakanthan V, Fitch S, et al. High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice. Stem Cell Res. 2015;14:307-22 pubmed 出版商
  170. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed 出版商
  171. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  172. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  173. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed 出版商
  174. Yeh I, de la Fouchardiere A, Pissaloux D, Mully T, Garrido M, Vemula S, et al. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions. Am J Surg Pathol. 2015;39:581-91 pubmed 出版商
  175. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed 出版商
  176. Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172-83 pubmed 出版商
  177. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed 出版商
  178. Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, et al. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015;6:3 pubmed 出版商
  179. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. 2015;14:370-5 pubmed 出版商
  180. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed 出版商
  181. Campbell J, Ratai E, Autissier P, Nolan D, Tse S, Miller A, et al. Anti-?4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014;10:e1004533 pubmed 出版商
  182. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed 出版商
  183. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed 出版商
  184. Neulen M, Viertlboeck B, Straub C, Göbel T. Identification of novel chicken CD4⁺ CD3⁻ blood population with NK cell like features. Dev Comp Immunol. 2015;49:72-8 pubmed 出版商
  185. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  186. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  187. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed 出版商
  188. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed 出版商
  189. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  190. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed 出版商
  191. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed 出版商
  192. Zhang Q, Chabot Richards D, Evans M, Spengel K, Andrews J, Kang H, et al. A retrospective study to assess the relative value of peripheral blood, bone marrow aspirate and biopsy morphology, immunohistochemical stains, and flow cytometric analysis in the diagnosis of chronic B cell lymphoproliferative neoplasms. Int J Lab Hematol. 2015;37:390-402 pubmed 出版商
  193. Balasa B, Yun R, Belmar N, Fox M, Chao D, Robbins M, et al. Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways. Cancer Immunol Immunother. 2015;64:61-73 pubmed 出版商
  194. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed 出版商
  195. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed 出版商
  196. Antsiferova O, Müller A, Rämer P, Chijioke O, Chatterjee B, Raykova A, et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014;10:e1004333 pubmed 出版商
  197. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  198. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed 出版商
  199. Reichwald K, Jørgensen T, Skov S. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS ONE. 2014;9:e105627 pubmed 出版商
  200. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed 出版商
  201. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed 出版商
  202. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed 出版商
  203. Han L, Yang J, Wang X, Wu Q, Yin S, Li Z, et al. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor ?t (ROR?t) in Th17 cells. J Biol Chem. 2014;289:25546-55 pubmed 出版商
  204. Herrera A, Kim H, Bindra B, Jones K, Alyea E, Armand P, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1737-43 pubmed 出版商
  205. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed 出版商
  206. Noyan F, Lee Y, Zimmermann K, Hardtke Wolenski M, Taubert R, Warnecke G, et al. Isolation of human antigen-specific regulatory T cells with high suppressive function. Eur J Immunol. 2014;44:2592-602 pubmed 出版商
  207. Kim K, Chung B, Kim B, Cho M, Yang C. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology. 2015;144:68-78 pubmed 出版商
  208. Campion S, Brodie T, Fischer W, Korber B, Rossetti A, Goonetilleke N, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211:1273-80 pubmed 出版商
  209. Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel T, et al. The impact of Nucleofection® on the activation state of primary human CD4 T cells. J Immunol Methods. 2014;408:123-31 pubmed 出版商
  210. Azzimonti B, Zavattaro E, Provasi M, Vidali M, Conca A, Catalano E, et al. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio. Br J Dermatol. 2015;172:64-73 pubmed 出版商
  211. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed 出版商
  212. Meira M, Sievers C, Hoffmann F, Rasenack M, Kuhle J, Derfuss T, et al. Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. J Immunol Res. 2014;2014:897249 pubmed 出版商
  213. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  214. Moreno Fernandez M, Joedicke J, Chougnet C. Regulatory T Cells Diminish HIV Infection in Dendritic Cells - Conventional CD4(+) T Cell Clusters. Front Immunol. 2014;5:199 pubmed 出版商
  215. Gautron A, Dominguez Villar M, de Marcken M, Hafler D. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol. 2014;44:2703-2711 pubmed 出版商
  216. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed 出版商
  217. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed 出版商
  218. Grage Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, Freitag Wolf S, et al. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol. 2014;8:982-97 pubmed 出版商
  219. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed 出版商
  220. Oetjen S, Mahlke C, Hermans Borgmeyer I, Hermey G. Spatiotemporal expression analysis of the growth factor receptor SorCS3. J Comp Neurol. 2014;522:3386-402 pubmed 出版商
  221. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed 出版商
  222. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed 出版商
  223. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed 出版商
  224. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  225. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed 出版商
  226. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed 出版商
  227. Sumitomo S, Fujio K, Okamura T, Morita K, Ishigaki K, Suzukawa K, et al. Transcription factor early growth response 3 is associated with the TGF-?1 expression and the regulatory activity of CD4-positive T cells in vivo. J Immunol. 2013;191:2351-9 pubmed 出版商
  228. Mitchell P, Afzali B, Fazekasova H, Chen D, Ali N, Powell N, et al. Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells. Clin Exp Immunol. 2012;170:300-9 pubmed 出版商
  229. Liang H, Reinhardt R, Bando J, Sullivan B, Ho I, Locksley R. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol. 2011;13:58-66 pubmed 出版商
  230. Xu H, Ye J, Chen Y, Zhang L, Huang J, Xian J, et al. Changes in the proportions of CD4(+)T cell subsets defined by CD127 and CD25 expression during HBV infection. Immunol Invest. 2012;41:290-303 pubmed 出版商
  231. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed 出版商
  232. Lee J, Hayman E, Pegram H, Santos E, Heller G, Sadelain M, et al. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy. Cancer Res. 2011;71:2871-81 pubmed 出版商
  233. Wu Y, Ren M, Yang R, Liang X, Ma Y, Tang Y, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 2011;13:R29 pubmed 出版商
  234. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, et al. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol. 2010;162:1056-63 pubmed 出版商
  235. Huntington N, Legrand N, Alves N, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206:25-34 pubmed 出版商
  236. Anderson A, Martens C, Hendrix R, Stempora L, Miller W, Hamby K, et al. Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses. Am J Transplant. 2008;8:2252-64 pubmed 出版商
  237. Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus. 2008;17:645-53 pubmed 出版商
  238. Amann M, Friedrich M, Lutterbuese P, Vieser E, Lorenczewski G, Petersen L, et al. Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans. Cancer Immunol Immunother. 2009;58:95-109 pubmed 出版商
  239. Yates J, Whittington A, Mitchell P, Lechler R, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol. 2008;153:44-55 pubmed 出版商
  240. Carvalho K, Maeda S, Marti L, Yamashita J, Haslett P, Kallas E. Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects. Immunology. 2008;124:206-14 pubmed 出版商
  241. Chen X, Molino C, Liu L, Gumbiner B. Structural elements necessary for oligomerization, trafficking, and cell sorting function of paraxial protocadherin. J Biol Chem. 2007;282:32128-37 pubmed
  242. Yates J, Rovis F, Mitchell P, Afzali B, Tsang J, Garin M, et al. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol. 2007;19:785-99 pubmed
  243. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  244. Yaddanapudi K, Palacios G, Towner J, Chen I, Sariol C, Nichol S, et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006;20:2519-30 pubmed 出版商
  245. Wichlan D, Roddam P, Eldridge P, Handgretinger R, Riberdy J. Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity. J Immunol Methods. 2006;315:27-36 pubmed
  246. Lawson C, Brown A, Bejarano V, Douglas S, Burgoyne C, Greenstein A, et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford). 2006;45:1210-7 pubmed
  247. Chen L, Cohen A, Lewis D. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol Blood Marrow Transplant. 2006;12:160-71 pubmed
  248. Miglio G, Varsaldi F, Lombardi G. Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun. 2005;338:1875-83 pubmed
  249. Lopez Santalla M, Valeri A, Perez Blas M, Aguilera Montilla N, Gutierrez A, Lasa I, et al. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma. Cancer Immunol Immunother. 2006;55:744-8 pubmed
  250. Siliciano J, Siliciano R. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005;304:3-15 pubmed
  251. Iking Konert C, Ostendorf B, Sander O, Jost M, Wagner C, Joosten L, et al. Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells. Ann Rheum Dis. 2005;64:1436-42 pubmed
  252. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  253. Aguilera Montilla N, Perez Blas M, Valeri A, Lopez Santalla M, Rodríguez Juan C, Mencia A, et al. Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scand J Gastroenterol. 2004;39:1236-42 pubmed
  254. Suskind D, Muench M. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J Hepatol. 2004;40:261-8 pubmed
  255. Camara N, Sebille F, Lechler R. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur J Immunol. 2003;33:3473-83 pubmed
  256. Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, et al. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol. 2003;30:1410-9 pubmed
  257. Valeri A, Perez Blas M, Gutierrez A, Lopez Santalla M, Aguilera N, Rodríguez Juan C, et al. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma. Cancer Immunol Immunother. 2003;52:708-14 pubmed
  258. Ng W, Duggan P, Ponchel F, Matarese G, Lombardi G, Edwards A, et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 2001;98:2736-44 pubmed
  259. Palmer E, Farrokh Siar L, Maguire van Seventer J, van Seventer G. IL-12 decreases activation-induced cell death in human naive Th cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function. J Immunol. 2001;167:749-58 pubmed
  260. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  261. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  262. Bank U, Reinhold D, Schneemilch C, Kunz D, Synowitz H, Ansorge S. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J Interferon Cytokine Res. 1999;19:1277-87 pubmed
  263. Vincent M, Roessner K, Sellati T, Huston C, Sigal L, Behar S, et al. Lyme arthritis synovial gamma delta T cells respond to Borrelia burgdorferi lipoproteins and lipidated hexapeptides. J Immunol. 1998;161:5762-71 pubmed
  264. Uchiyama T, Nelson D, Fleisher T, Waldmann T. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol. 1981;126:1398-403 pubmed